6 completed, 2 unknown, 1 terminated, 1 withdrawn. 3 Phase 4, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Nephrogenic Fibrosing Dermopathy: new trials by email Literature Review of Nephrogenic Fibrosing Dermopathy trials Research Report on Nephrogenic Fibrosing Dermopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging Gadodiamide, Gadoteric Acid Meglumine Salt - Nephrogenic Fibrosing Dermopathy | Phase 4 | Unknown | The Central Hospital of Lishui City | 600 | 2021-03-01 | 2021-03-01 |
| Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR Ablavar - Nephrogenic Systemic Fibrosis | Completed | Lantheus Medical Imaging | 2 | 2009-10-01 | 2014-05-07 | |
| Treatment of Patients With Nephrogenic Systemic Fibrosis With Glivec Imatinib mesylate (Glivec) - Nephrogenic Systemic Fibrosis | Phase 3 | Completed | University of Aarhus | 10 | 2009-09-01 | 2012-06-05 |
| Primovist / Eovist in Renally Impaired Patients Gadoxetic acid disodium (Primovist, BAY86-4873) - Contrast Media | Phase 4 | Completed | Bayer | 357 | 2009-05-01 | 2015-07-23 |
| Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis Nephrogenic Systemic Fibrosis | Completed | Massachusetts General Hospital | 60 | 2009-03-01 | 2010-12-15 | |
| Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection Nephrogenic Systemic Fibrosis, Renal Insufficiency | Withdrawn | Guerbet | 2009-02-01 | 2017-08-02 | ||
| Nephrogenic Systemic Fibrosis With Gadollinum gadollinum - Nephrogenic Systemic Fibrosis, Renal Failure | Phase 2 / Phase 3 | Unknown | Imam Khomeini Hospital | 200 | 2008-07-01 | 2012-06-22 |
| Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis Imatinib mesylate - Nephrogenic Systemic Fibrosis | Phase 2 | Completed | Massachusetts General Hospital | 12 | 2007-12-01 | 2017-05-19 |
| Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels Nephrogenic Systemic Fibrosis, Nephrogenic Fibrosing Dermopathy | Completed | Northwestern University | 24 | 2007-08-01 | 2014-12-04 | |
| Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) Plasmapheresis - Nephrogenic Fibrosing Dermopathy, Nephrogenic Systemic Fibrosis | Phase 4 | Terminated | Loma Linda University | 12 | 2002-02-01 | 2014-11-21 |
Renal Insufficiency (3) · Kidney Diseases (1) · Kidney Failure, Chronic (1) · Renal Insufficiency, Chronic (1)
Fibrosis (10) · Pathologic Processes (10) · Pathological Conditions, Signs and Symptoms (10) · Skin Diseases (10) · Skin and Connective Tissue Diseases (10) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Male Urogenital Diseases (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Kidney Diseases (4) · Chronic Disease (2) · Disease Attributes (2) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Imatinib Mesylate (2) · Plasmapheresis (1) · gadodiamide (1) · gadolinium ethoxybenzyl DTPA (1)
Massachusetts General Hospital (2) · Bayer (1) · Guerbet (1) · Imam Khomeini Hospital (1) · Lantheus Medical Imaging (1) · Loma Linda University (1) · Northwestern University (1) · The Central Hospital of Lishui City (1) · University of Aarhus (1)
United States (7) · Australia (1) · Austria (1) · China (1) · Denmark (1) · Germany (1) · Iran (1) · Italy (1) · South Korea (1) · Spain (1) · Thailand (1) · United Kingdom (1)
Jonathan Kay, MD (2) · Anne B Olesen, MD,PhD (1) · Anne Laumann, MBChB, MRCP(UK) (1) · Herbert R. Neuman, MD (1) · Mohammad R Khatami, MD (1) · Pedro Baron, MD (1) · Simon P Robinson, PhD (1)
2008 (1)